Serum Markers in Preeclamptic Women
Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01361737
Collaborator
(none)
1
64
Study Details
Study Description
Brief Summary
Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Observational Model:
Case-Control
Time Perspective:
Retrospective
Study Start Date
:
Jan 1, 1999
Actual Primary Completion Date
:
Jan 1, 1999
Actual Study Completion Date
:
May 1, 2004
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| preeclampsia Control group: 86 healthy women not developing preeclampsia (PE) Case group: 43 women developing PE |
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- previous healthy
Exclusion Criteria:
- Previous inflammatory diseases
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Oslo University Hospital, Rikshospitalet | Oslo | Norway | 0027 |
Sponsors and Collaborators
- Oslo University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT01361737
Other Study ID Numbers:
- NOSERPE11
First Posted:
May 27, 2011
Last Update Posted:
Jul 6, 2011
Last Verified:
May 1, 2011
Keywords provided by ,
,
Additional relevant MeSH terms: